Moneycontrol PRO
Open App
you are here: HomeNewsIndia

Rise in active COVID-19 cases in Maharashtra alarming: Health Minister Rajesh Tope

Maharashtra Health Minister Rajesh Tope said in the last 8-10 days, the active cases in the state stood in the range of 5,000-6,000. On Tuesday, the state had 11,492 active cases.

December 29, 2021 / 02:38 PM IST
Source: AP

Source: AP

Maharashtra Health Minister Rajesh Tope on Wednesday expressed concern over the rise in the number of fresh as well as active COVID-19 cases in the state, and termed it as an alarming situation.

Talking to reporters here, Tope urged people and authorities to exercise caution.

He said in the last 8-10 days, the active cases in the state stood in the range of 5,000-6,000. On Tuesday, the state had 11,492 active cases. On Wednesday, the number of active cases could rise over 20,000, he said.

The rise in active cases in the state is alarming, the minister said. He also expressed concern over the fast doubling rate of cases in the state, and the rising number of infections in Mumbai.

On Tuesday, Maharashtra reported 2,172 fresh coronavirus cases, up by 50 per cent from 1,426 infections recorded a day before, and 22 new deaths, the health department earlier said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

With these additions, the state’s COVID-19 tally rose to 66,61,486, while the death toll increased to 1,41,476, it said.

(With PTI inputs)
Moneycontrol News
first published: Dec 29, 2021 02:38 pm
ISO 27001 - BSI Assurance Mark